Education
About Us
Working with TipRanks
Follow Us
2Seventy Bio, Inc. (TSVT)
NASDAQ:TSVT
Total Valuation
2seventy bio has a market cap or net worth of $266.15M. The enterprise value is ―.
Market Cap$266.15M
Enterprise Value―
Share Statistics
2seventy bio has 53,229,790 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,229,790
Owned by Insiders10.07%
Owned by Institutions<0.01%
Financial Efficiency
2seventy bio’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -25.33%.
Return on Equity (ROE)-0.27
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-25.33%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee582.49K
Profits Per Employee-880.72K
Employee Count65
Asset Turnover0.08
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of 2seventy bio is -2.68. 2seventy bio’s PEG ratio is -0.11.
PE Ratio-2.68
PS Ratio0.00
PB Ratio1.23
Price to Fair Value0.73
Price to FCF-3.02
Price to Operating Cash Flow-3.04
PEG Ratio-0.11
Income Statement
In the last 12 months, 2seventy bio had revenue of 37.86M and earned -57.25M in profits. Earnings per share was -1.10.
Revenue37.86M
Gross Profit37.86M
Operating Income-115.43M
Pretax Income-57.25M
Net Income-57.25M
EBITDA-98.45M
Earnings Per Share (EPS)-1.10
Cash Flow
In the last 12 months, operating cash flow was -85.00M and capital expenditures -707.00K, giving a free cash flow of -85.70M billion.
Operating Cash Flow-85.00M
Free Cash Flow-85.70M
Free Cash Flow per Share-1.61
Dividends & Yields
2seventy bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.42
52-Week Price Change9.65%
50-Day Moving Average4.69
200-Day Moving Average4.06
Relative Strength Index (RSI)72.25
Average Volume (3m)1.05M
Important Dates
2seventy bio upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
2seventy bio as a current ratio of 4.67, with Debt / Equity ratio of 115.61%
Current Ratio4.67
Quick Ratio4.67
Debt to Market Cap1.59
Net Debt to EBITDA-1.75
Interest Coverage Ratio0.00
Taxes
In the past 12 months, 2seventy bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
2seventy bio EV to EBITDA ratio is -3.31, with an EV/FCF ratio of -3.80.
EV to Sales8.61
EV to EBITDA-3.31
EV to Free Cash Flow-3.80
EV to Operating Cash Flow-3.84
Balance Sheet
2seventy bio has $174.75M in cash and marketable securities with $243.72M in debt, giving a net cash position of $68.96M billion.
Cash & Marketable Securities$174.75M
Total Debt$243.72M
Net Cash$68.96M
Net Cash Per Share$1.30
Tangible Book Value Per Share$3.92
Margins
Gross margin is 34.84%, with operating margin of -304.87%, and net profit margin of -151.20%.
Gross Margin34.84%
Operating Margin-304.87%
Pretax Margin-151.20%
Net Profit Margin-151.20%
EBITDA Margin-260.01%
EBIT Margin-278.75%
Analyst Forecast
The average price target for 2seventy bio is $5.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.00
Price Target Upside0.00%
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast-32.07%
EPS Growth Forecast98.22%